Bloomberg data indicates that averaged over all ratings the firm has an average target price of $80.92 which represents significant growth potential moving forward. In conclusion, analysts are optimistic about Cardinal Health’s future prospects with nine investment analysts rating it as a “hold” while four deem it worthy of a “buy”, including one who rated CAH as “strong buy”. Institutional investors seem to be bullish on Cardinal Health as evidenced by these moves which account for a massive 88.93% ownership of the company’s stock between hospital systems and hedge funds. Sei Investments Co has also increased its position by 6.% during Q1/2021 and now owns approximately $26.79 million worth of CAH stock or around 472k shares of the company. increased its position in Cardinal Health by 53.6% during the last quarter to now own 25,616 shares worth $1.45 million while Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted their position by 4.8%, owning 37,071 shares valued at $2.10 million after buying an additional 1,702 shares last quarter.Īdditionally, Cibc World Market Inc acquired a new stake in Cardinal Health worth around $212k earlier this year while Blair William & Co IL boosted its position by 6.7% during the last quarter now holding roughly $667k or 11,769 shares of the company’s stock. Recently, several hedge funds and institutional investors have been actively buying and selling shares of CAH. Its portfolio also includes medical products and pharmaceuticals that work to enhance patient care. With customized solutions for hospitals, healthcare centers, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices, it is well-positioned to improve supply chain efficiency in the sector. Institutional Investors Bullish on Cardinal Health: Potential Investment Opportunity in the Healthcare Services IndustryĬardinal Health, Inc is a leading player in the healthcare services and products industry. The move serves to demonstrate not just the fundamentals of Cardinal Health but also the ingenuity of Metis Global Partners LLC as a force within the investment management sector. In conclusion, Metis Global Partners LLC’s significant growth in stake is proof that Cardinal Health, Inc is one stock to watch in the coming months as it continues to consolidate its position as an innovative provider of quality healthcare services and products across different markets. As such, the company has seen a fifty-two week high of $83.01 and a fifty-two week low of $49.70 – underscoring the reliability and stability of its position in the industry. The company’s current financial standing is strong with revenue growth of over $39 billion recorded from fiscal year 2020 alongside consistent dividend payments given to its shareholders regularly over the years driving investor confidence even higher.Ĭardinal Health’s stock has been performing exceptionally well recently buoyed by general optimism surrounding healthcare stocks in the current economic climate. The stock has a price-to-earnings ratio (P/E) of 14.98 along with a price-to-earnings-growth ratio (PEG) of 1.30 and a beta of 0.74 – all indicating reasonable valuation metrics for investors. Trading under the ticker symbol “CAH,” Cardinal Health opened at $81.64 on Thursday with a market cap of $21.03 billion. The company also provides medical products and pharmaceuticals across different markets globally. These solutions are designed to meet the specific needs and requirements of hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. With its extensive experience in identifying promising companies poised for growth within their industries coupled with their proven track record of success, this move by Metis Global Partners LLC is sure to garner attention within the financial sector.Ĭardinal Health offers a range of services and products that provide cost-effective solutions that aim to enhance supply chain efficiency. According to the company’s most recent 13F filing with the Securities and Exchange Commission (SEC), Metis Global Partners LLC’s holdings in Cardinal Health increased by an astonishing 113.8% during the fourth quarter of last year.Īs a result of this surge in investment, the firm now owns over 8,500 shares of Cardinal Health stock, valued at $657,000 as of its most recent SEC filing. Metis Global Partners LLC, a leading investment management firm, has reported significant growth in its stake in Cardinal Health, Inc (NYSE: CAH), a healthcare services and products company specializing in customized solutions for various medical facilities.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |